Autolus Therapeutics to Report Second Quarter 2022 Financial Results on August 4, 2022
Autolus Therapeutics plc (Nasdaq: AUTL) will announce its Q2 2022 financial results and operational highlights on August 4, 2022, prior to the U.S. market opening. A conference call and webcast featuring management will occur at 8:30 am ET to discuss the results and provide an update on the company's business. Participants can pre-register for the call to receive dial-in numbers and PINs. The audio webcast will also be accessible on the company's website.
- None.
- None.
LONDON, July 21, 2022 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its second quarter 2022 financial results and operational highlights before open of U.S. markets on Thursday, August 4, 2022.
Management will host a conference call and webcast at 8:30 am ET/1:30 pm BST to discuss the company’s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call.
A simultaneous audio webcast and replay will be accessible on the events section of Autolus’ website.
Contact:
Olivia Manser
+44 (0) 7780 471568
o.manser@autolus.com
Julia Wilson
+44 (0) 7818 430877
j.wilson@autolus.com
Susan A. Noonan
S.A. Noonan Communications
+1-917-513-5303
susan@sanoonan.com
FAQ
When will Autolus Therapeutics announce its Q2 2022 financial results?
What time is the Autolus Therapeutics conference call?
How can I access the Autolus Therapeutics financial results webcast?
What is the purpose of the conference call by Autolus Therapeutics?
